Expert interview
Yelak Biru
Date: Dec 1, 2024
Duration: 3:21
Content Type: Interview
Category: Multiple Myeloma
Audience Type: Primary Care Provider
About the interview
In this interview, Yelak Biru, a multiple myeloma patient and former CEO of the International Myeloma Foundation, shares his personal journey and insights into the importance of timely diagnosis and comprehensive care. Diagnosed with multiple myeloma at the age of 25, Yelak emphasizes the critical role primary care physicians play in identifying and managing the disease. He discusses the varied experiences of myeloma patients and the need for early detection and ongoing support to help patients live full lives despite their diagnosis.
Key discussion points:
- Yelak’s personal journey with multiple myeloma, in which he was given a prognosis of 2-3 years to live at the age of 25
- The importance of timely diagnosis, which significantly impacted his survival
- Varied experiences of myeloma patients, including those who struggle with symptoms for years before diagnosis
- Primary care physicians’ role in early detection and ongoing management of multiple myeloma
- The importance of regular monitoring for treatment-related side effects, such as recurring infections
Featured speaker
Yelak Biru
Multiple myeloma patient & former CEO of the International Myeloma Foundation,
Insights to your inbox
Sign up below to get lorem ipsum dolor sit amet inos a consecte tura adipiscing elit proinas inosam.
Understanding the multiple myeloma workup with Dr. Kumar
Dr. Kumar outlines the diagnostic steps for multiple myeloma, including lab tests, imaging, and the importance of monitoring disease progression.
Learn more
Multiple myeloma testing and disparities with Dr. Landgren
Dr. Landgren explains how blood tests and genomics aid early myeloma diagnosis, and highlights the need for better care in at-risk African American communities.
Learn more
Our mission is to enable our customers to make the world healthier, cleaner and safer
© Thermo Fisher Scientific Inc. All Rights Reserved.